| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.52 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |